VOYA Investment Management’s Alexion Pharmaceuticals ALXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-105,492
| Closed | -$19.4M | – | 2857 |
|
|
2021
Q2 | $19.4M | Sell |
105,492
-14,028
| -12% | -$2.41M | 0.04% | 359 |
|
|
2021
Q1 | $18.3M | Sell |
119,520
-2,017
| -2% | -$312K | 0.04% | 369 |
|
|
2020
Q4 | $19M | Buy |
121,537
+7,991
| +7% | +$1.03M | 0.04% | 361 |
|
|
2020
Q3 | $13M | Sell |
113,546
-3,162
| -3% | -$341K | 0.03% | 443 |
|
|
2020
Q2 | $13.1M | Buy |
116,708
+25,643
| +28% | +$2.72M | 0.03% | 433 |
|
|
2020
Q1 | $8.18M | Sell |
91,065
-1,712
| -2% | -$168K | 0.02% | 550 |
|
|
2019
Q4 | $10M | Buy |
92,777
+6,173
| +7% | +$660K | 0.02% | 612 |
|
|
2019
Q3 | $8.48M | Sell |
86,604
-864
| -1% | -$97.4K | 0.02% | 642 |
|
|
2019
Q2 | $11.5M | Buy |
87,468
+6,447
| +8% | +$831K | 0.02% | 561 |
|
|
2019
Q1 | $11M | Buy |
81,021
+1,052
| +1% | +$131K | 0.02% | 549 |
|
|
2018
Q4 | $7.79M | Buy |
79,969
+259
| +0.3% | +$30.6K | 0.02% | 619 |
|
|
2018
Q3 | $11.1M | Sell |
79,710
-1,642
| -2% | -$206K | 0.02% | 578 |
|
|
2018
Q2 | $10.1M | Buy |
81,352
+2,093
| +3% | +$245K | 0.02% | 598 |
|
|
2018
Q1 | $8.83M | Sell |
79,259
-1,585
| -2% | -$189K | 0.02% | 632 |
|
|
2017
Q4 | $9.67M | Sell |
80,844
-3,618
| -4% | -$441K | 0.02% | 617 |
|
|
2017
Q3 | $11.8M | Sell |
84,462
-1,966
| -2% | -$267K | 0.03% | 551 |
|
|
2017
Q2 | $10.5M | Buy |
86,428
+1,143
| +1% | +$133K | 0.02% | 594 |
|
|
2017
Q1 | $10.3M | Buy |
85,285
+86
| +0.1% | +$11.1K | 0.02% | 598 |
|
|
2016
Q4 | $10.4M | Buy |
85,199
+553
| +0.7% | +$67.7K | 0.02% | 568 |
|
|
2016
Q3 | $10.4K | Buy |
84,646
+26
| +0% | +$3.35K | 0.02% | 577 |
|
|
2016
Q2 | $9.88M | Sell |
84,620
-1,127
| -1% | -$160K | 0.02% | 573 |
|
|
2016
Q1 | $11.9M | Sell |
85,747
-1,417
| -2% | -$208K | 0.03% | 490 |
|
|
2015
Q4 | $16.6M | Sell |
87,164
-2,255
| -3% | -$394K | 0.04% | 398 |
|
|
2015
Q3 | $14M | Buy |
89,419
+2,455
| +3% | +$448K | 0.04% | 437 |
|
|
2015
Q2 | $15.7M | Sell |
86,964
-1,010,587
| -92% | -$174M | 0.04% | 425 |
|
|
2015
Q1 | $190M | Buy |
1,097,551
+155,347
| +16% | +$28.1M | 0.42% | 71 |
|
|
2014
Q4 | $174M | Buy |
942,204
+173,229
| +23% | +$32.1M | 0.39% | 70 |
|
|
2014
Q3 | $128M | Buy |
768,975
+160,806
| +26% | +$26.4M | 0.29% | 90 |
|
|
2014
Q2 | $95M | Sell |
608,169
-307,509
| -34% | -$48.6M | 0.22% | 114 |
|
|
2014
Q1 | $139M | Buy |
915,678
+88,630
| +11% | +$14.1M | 0.32% | 79 |
|
|
2013
Q4 | $110M | Buy |
827,048
+90,751
| +12% | +$10.9M | 0.25% | 95 |
|
|
2013
Q3 | $85.5M | Buy |
736,297
+293,378
| +66% | +$32.2M | 0.21% | 118 |
|
|
2013
Q2 | $40.9M | Buy |
+442,919
| New | +$42.7M | 0.11% | 173 |
|
Other funds holding ALXN
BCI
NICM
TAIM
RG
CFO
MAM